A flavin-dependent monooxygenase from Mycobacterium tuberculosis involved in cholesterol catabolism.
Mycobacterium tuberculosis (Mtb) and Rhodococcus jostii RHA1 have similar cholesterol catabolic pathways. This pathway contributes to the pathogenicity of Mtb. The hsaAB cholesterol catabolic genes have been predicted to encode the oxygenase and reductase, respectively, of a flavin-dependent mono-oxygenase that hydroxylates 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione (3-HSA) to a catechol. An hsaA deletion mutant of RHA1 did not grow on cholesterol but transformed the latter to 3-HSA and related metabolites in which each of the two keto groups was reduced: 3,9-dihydroxy-9,10-seconandrost-1,3,5(10)-triene-17-one (3,9-DHSA) and 3,17-dihydroxy-9,10-seconandrost-1,3,5(10)-triene-9-one (3,17-DHSA). Purified 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione 4-hydroxylase (HsaAB) from Mtb had higher specificity for 3-HSA than for 3,17-DHSA (apparent k(cat)/K(m) = 1000 +/- 100 M(-1) s(-1) versus 700 +/- 100 M(-1) s(-1)). However, 3,9-DHSA was a poorer substrate than 3-hydroxybiphenyl (apparent k(cat)/K(m) = 80 +/- 40 M(-1) s(-1)). In the presence of 3-HSA the K(m)(app) for O(2) was 100 +/- 10 microM. The crystal structure of HsaA to 2.5-A resolution revealed that the enzyme has the same fold, flavin-binding site, and catalytic residues as p-hydroxyphenyl acetate hydroxylase. However, HsaA has a much larger phenol-binding site, consistent with the enzyme's substrate specificity. In addition, a second crystal form of HsaA revealed that a C-terminal flap (Val(367)-Val(394)) could adopt two conformations differing by a rigid body rotation of 25 degrees around Arg(366). This rotation appears to gate the likely flavin entrance to the active site. In docking studies with 3-HSA and flavin, the closed conformation provided a rationale for the enzyme's substrate specificity. Overall, the structural and functional data establish the physiological role of HsaAB and provide a basis to further investigate an important class of monooxygenases as well as the bacterial catabolism of steroids.
Dresen
Carola
C
Department of Microbiology and Immunology, University of British Columbia, Vancouver V6T 1Z3, Canada.
Lin
Leo Y-C
LY
D'Angelo
Igor
I
Tocheva
Elitza I
EI
Strynadka
Natalie
N
Eltis
Lindsay D
LD
D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D001665:Binding Sites; D055162:Biocatalysis; D002784:Cholesterol / Q000378:metabolism*; D018360:Crystallography, X-Ray; D005415:Flavins / Q000378:metabolism*; D008401:Gas Chromatography-Mass Spectrometry; D017353:Gene Deletion; D006900:Hydroxylation; D007700:Kinetics; D006899:Mixed Function Oxygenases / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D008958:Models, Molecular; D009169:Mycobacterium tuberculosis / Q000201:enzymology*; D010641:Phenotype; D017433:Protein Structure, Secondary
D001426:Bacterial Proteins; D005415:Flavins; D002784:Cholesterol; D006899:Mixed Function Oxygenases
J Biol Chem. 2009 Apr 10;284(15):9937-46
19234303
J Bacteriol. 1995 Sep;177(18):5199-205
7665508
Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1355-63
15272157
Annu Rev Microbiol. 2003;57:517-49
14527290
J Bacteriol. 2003 May;185(9):2786-92
12700257
Am J Pathol. 2006 Apr;168(4):1249-61
16565499
Annu Rev Pharmacol Toxicol. 2005;45:529-64
15822188
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7
15980490
Protein Eng. 1994 Sep;7(9):1145-50
7831286
J Bacteriol. 1997 Jul;179(13):4403-6
9209061
Mol Microbiol. 2002 Aug;45(4):1007-18
12180920
J Bacteriol. 1997 Feb;179(4):1112-6
9023192
Biochemistry. 2007 Aug 7;46(31):9058-67
17630785
Curr Opin Microbiol. 2004 Jun;7(3):255-61
15196492
Eur J Biochem. 1997 Nov 1;249(3):739-47
9395321
J Biol Chem. 2006 Jun 23;281(25):17044-17053
16627482
Anal Biochem. 1976 May 7;72:248-54
942051
J Bacteriol. 1998 Aug;180(15):3823-7
9683478
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
15299926
J Biol Chem. 1999 Sep 17;274(38):26639-46
10480865
Acta Crystallogr D Biol Crystallogr. 1999 Feb;55(Pt 2):484-91
10089360
Appl Environ Microbiol. 2010 Jan;76(1):352-5
19880645
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
9757107
J Comput Chem. 2009 Dec;30(16):2785-91
19399780
J Biol Chem. 2010 Jan 1;285(1):434-43
19875455
Lancet. 2006 Mar 18;367(9514):938-40
16546542
Biochem Biophys Res Commun. 2005 Dec 9;338(1):590-8
16236251
Methods Enzymol. 1997;276:307-26
27754618
Biochemistry. 2005 Aug 2;44(30):10434-42
16042421
J Bacteriol. 2000 Feb;182(3):627-36
10633095
Appl Environ Microbiol. 1998 Jul;64(7):2479-84
9647818
Appl Environ Microbiol. 2004 Sep;70(9):5557-68
15345444
J Bacteriol. 1996 May;178(9):2645-9
8626333
Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1947-52
17264217
Appl Environ Microbiol. 1995 Sep;61(9):3353-8
16535122
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8327-32
15928073
PLoS Pathog. 2009 Mar;5(3):e1000344
19300498
Anal Biochem. 1973 May;53(1):332-6
4145740
Microbiology (Reading). 2002 Oct;148(Pt 10):3285-3292
12368462
J Mol Model. 2007 Dec;13(12):1173-213
17828561
Infect Immun. 2010 Jan;78(1):275-82
19822655
Mol Microbiol. 2010 Jan;75(1):107-21
19906176
Mol Microbiol. 2009 Dec;74(5):1031-43
19843222
Eur J Biochem. 2001 Nov;268(21):5550-61
11683878
Appl Environ Microbiol. 2000 Feb;66(2):481-6
10653707
J Biol Chem. 1998 Dec 25;273(52):34887-95
9857017
Biochemistry. 2007 Jul 24;46(29):8611-23
17595116
J Biol Chem. 2008 Apr 18;283(16):10287-96
18245777
Appl Environ Microbiol. 2000 May;66(5):2029-36
10788377
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4376-80
18334639